|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112 - 10339
|
$257,863
|
$103,145
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185 - 10361
|
$32,990
|
$9,897
|
Abnet, Christian
|
DCEG (NCI)
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$7,372
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$61,039
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$12,959
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-04
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$2,500
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$6,223
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-05
|
$303,118
|
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
|
1R01CA228272-01
|
$659,504
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
5R01CA185623-05
|
$1,038,141
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Dopamine as a therapeutic agent in stomach cancer
|
5R01CA169158-03
|
$319,550
|
$319,550
|
BASU, SUJIT
|
OHIO STATE UNIVERSITY
|
|
Targeting Mucin and EGFR Axis in Pancreatic Cancer
|
5R01CA183459-05
|
$311,659
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Proliferation and Differentiation of Bladder Epithelial Cells in Regeneration and Malignancy
|
2R01CA157877-06A1
|
$507,988
|
|
BEACHY, PHILIP
|
STANFORD UNIVERSITY
|
|
Iowa-Wide Oncology Research Coalition (I-WORC)
|
5UG1CA189816-05
|
$1,177,581
|
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-33S1
|
$62,500
|
$625
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
$25,291
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-02S2
|
$34,899
|
$698
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-02
|
$10,609,226
|
$212,185
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG NCORP Research Base
|
5UG1CA189974-05
|
$4,973,785
|
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
|
5K07CA211847-03
|
$133,475
|
|
BONA, KIRA
|
DANA-FARBER CANCER INST
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$340,579
|
$17,029
|
Bottaro, Donald
|
CCR (NCI)
|
|
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
|
5R01CA199143-03
|
$568,985
|
|
BRANDON, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
|
5U01CA195603-04
|
$443,239
|
|
BRENNAN, PAUL
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-02
|
$898,445
|
$22,461
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-03
|
$2,300,000
|
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Quantitative Imaging to Assess Response in Cancer Therapy Trials
|
5U01CA140206-09
|
$622,467
|
|
BUATTI, JOHN
|
UNIVERSITY OF IOWA
|
|
The Dynamics of Smoking Cessation After Cancer Diagnosis: A Naturalisitic Study
|
5K07CA181351-05
|
$153,314
|
|
BURRIS, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-02
|
$1,171,980
|
$29,300
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
|
5U01CA217858-02
|
$1,314,469
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA016058-39S1
|
$62,500
|
$625
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S2
|
$60,126
|
$601
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S3
|
$31,250
|
$313
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-39
|
$4,582,303
|
$45,823
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Role of the hexosamine biosynthesis pathway in pancreatic cancer.
|
5F31CA217070-02
|
$44,524
|
|
CAMPBELL, SYDNEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Georgia NCI Community Oncology Research Program (NCORP)
|
5UG1CA189997-05
|
$1,521,071
|
|
CANTUARIA, GUILHERME
|
NORTHSIDE HOSPITAL ATLANTA
|
Total relevant funding to Stomach for this search: $14,810,486
|